Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/184331
Title: Antibody conversion rates to SARS-CoV-2 in saliva from children attending summer schools in Barcelona, Spain.
Author: Dobaño, Carlota, 1969-
Alonso, Selena
Fernández de Sevilla, M
Vidal, Marta
Jiménez, Alfons
Pons Tomas, Gemma
Jairoce, Chenjerai
Melé Casas, María
Rubio, Rocío
Hernández García, María
Ruiz Olalla, Gemma
Girona Alarcón, Mònica
Barrios, Diana
Santano, Rebeca
Mitchell, Robert A.
Puyol, Laura
Mayer, Leonie
Chi, Jordi
Rodrigo Melero, Natalia
Carolis, Carlo
Garcia Miquel, Aleix
Bonet Carné, Elisenda
Claverol, Joana
Cubells, Marta
Fortuny Guasch, Claudia
Fumadó, Victoria
Jou, Cristina
Muñoz Almagro, Carmen
Izquierdo, Luis
Bassat Orellana, Quique
Gratacós Solsona, Eduard
Aguilar, Ruth
García García, Juan José
Moncunill, Gemma
Jordan Garcia, Iolanda
Keywords: SARS-CoV-2
Infants
Entorn escolar
Saliva
Antígens
SARS-CoV-2
Children
School environment
Saliva
Antigens
Issue Date: 23-Nov-2021
Publisher: BioMed Central
Abstract: Background: Surveillance tools to estimate viral transmission dynamics in young populations are essential to guide recommendations for school opening and management during viral epidemics. Ideally, sensitive techniques are required to detect low viral load exposures among asymptomatic children. We aimed to estimate SARS-CoV-2 infection rates in children and adult populations in a school-like environment during the initial COVID-19 pandemic waves using an antibody-based field-deployable and non-invasive approach. Methods: Saliva antibody conversion defined as ≥ 4-fold increase in IgM, IgA, and/or IgG levels to five SARS-CoV-2 antigens including spike and nucleocapsid constructs was evaluated in 1509 children and 396 adults by high-throughput Luminex assays in samples collected weekly in 22 summer schools and 2 pre-schools in 27 venues in Barcelona, Spain, from June 29th to July 31st, 2020. Results: Saliva antibody conversion between two visits over a 5-week period was 3.22% (49/1518) or 2.36% if accounting for potentially cross-reactive antibodies, six times higher than the cumulative infection rate (0.53%) assessed by weekly saliva RT-PCR screening. IgG conversion was higher in adults (2.94%, 11/374) than children (1.31%, 15/1144) (p=0.035), IgG and IgA levels moderately increased with age, and antibodies were higher in females. Most antibody converters increased both IgG and IgA antibodies but some augmented either IgG or IgA, with a faster decay over time for IgA than IgG. Nucleocapsid rather than spike was the main antigen target. Anti-spike antibodies were significantly higher in individuals not reporting symptoms than symptomatic individuals, suggesting a protective role against COVID-19. Conclusion: Saliva antibody profiling including three isotypes and multiplexing antigens is a useful and user-friendlier tool for screening pediatric populations to detect low viral load exposures among children, particularly while they are not vaccinated and vulnerable to highly contagious variants, and to recommend public health policies during pandemics.
Note: Reproducció del document publicat a: https://doi.org/10.1186/s12916-021-02184-1
It is part of: BMC Medicine, 2021, vol. 19, num. 1, p. 309
URI: http://hdl.handle.net/2445/184331
Related resource: https://doi.org/10.1186/s12916-021-02184-1
ISSN: 1741-7015
Appears in Collections:Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer)
Articles publicats en revistes (Cirurgia i Especialitats Medicoquirúrgiques)
Articles publicats en revistes (BCNatal Fetal Medicine Research Center)
Articles publicats en revistes (ISGlobal)

Files in This Item:
File Description SizeFormat 
718373.pdf4.6 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons